NRx Pharmaceuticals Statistics

Total Valuation

NRXP has a market cap or net worth of $66.31 million. The enterprise value is $69.38 million.

Market Cap	66.31M
Enterprise Value	69.38M

Important Dates

The last earnings date was Monday, November 17, 2025, before market open.

Earnings Date	Nov 17, 2025
Ex-Dividend Date	n/a

Share Statistics

NRXP has 28.10 million shares outstanding. The number of shares has increased by 79.43% in one year.

Current Share Class	28.10M
Shares Outstanding	28.10M
Shares Change (YoY)	+79.43%
Shares Change (QoQ)	+23.96%
Owned by Insiders (%)	6.34%
Owned by Institutions (%)	6.89%
Float	20.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	34.10
PS Ratio	167.98
Forward PS	0.66
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	286.70
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.29

Current Ratio	0.29
Quick Ratio	0.26
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-97.83%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	59.49%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +93.44% in the last 52 weeks. The beta is 1.92, so NRXP's price volatility has been higher than the market average.

Beta (5Y)	1.92
52-Week Price Change	+93.44%
50-Day Moving Average	2.83
200-Day Moving Average	2.64
Relative Strength Index (RSI)	45.30
Average Volume (20 Days)	446,301

Short Selling Information

The latest short interest is 1.36 million, so 4.83% of the outstanding shares have been sold short.

Short Interest	1.36M
Short Previous Month	860,796
Short % of Shares Out	4.83%
Short % of Float	6.68%
Short Ratio (days to cover)	3.01

Income Statement

In the last 12 months, NRXP had revenue of $242,000 and -$38.06 million in losses. Loss per share was -$2.21.

Revenue	242,000
Gross Profit	145,000
Operating Income	-15.23M
Pretax Income	-38.06M
Net Income	-38.06M
EBITDA	-15.20M
EBIT	-15.23M
Loss Per Share	-$2.21

Full Income Statement

Balance Sheet

The company has $7.18 million in cash and $10.26 million in debt, giving a net cash position of -$3.07 million or -$0.11 per share.

Cash & Cash Equivalents	7.18M
Total Debt	10.26M
Net Cash	-3.07M
Net Cash Per Share	-$0.11
Equity (Book Value)	-25.76M
Book Value Per Share	-0.93
Working Capital	-28.65M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-12.50M
Capital Expenditures	n/a
Free Cash Flow	-12.50M
FCF Per Share	-$0.44

Full Cash Flow Statement

Margins

Gross Margin	59.92%
Operating Margin	-6,292.56%
Pretax Margin	-15,727.27%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NRXP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-79.43%
Shareholder Yield	-79.43%
Earnings Yield	-57.40%
FCF Yield	-18.85%

Analyst Forecast

The average price target for NRXP is $30.50, which is 1,192.37% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$30.50
Price Target Difference	1,192.37%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 2, 2024. It was a reverse split with a ratio of 1:10.

Last Split Date	Apr 2, 2024
Split Type	Reverse
Split Ratio	1:10

Scores

NRXP has an Altman Z-Score of -33.71 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-33.71
Piotroski F-Score	2